AnaptysBio
ANAB
ANAB
135 hedge funds and large institutions have $469M invested in AnaptysBio in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 35 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
39% less call options, than puts
Call options by funds: $21M | Put options by funds: $34.3M
48% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 52
58% less capital invested
Capital invested by funds: $1.13B → $469M (-$658M)
Holders
135
Holding in Top 10
2
Calls
$21M
Puts
$34.3M
Top Buyers
| 1 | +$24.1M | |
| 2 | +$16.6M | |
| 3 | +$5.48M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.03M |
| 5 |
BlackRock
New York
|
+$4.88M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$11.5M | |
| 3 | -$10.2M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.84M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$8.41M |